| LP449076-1 | Thrombin receptor activating peptide-6 induced | METHOD | |
| LP449077-9 | Tissue factor induced | METHOD | |
| LP449078-7 | Thromboelastography.resonance.tissue factor induced with platelet glycoprotein IIb-IIIa receptor inhibited | METHOD | 1 |
| LP449079-5 | Prothrombin time (PT) factor substitution 1H post incubation with 1:1 normal plasma | METHOD | 1 |
| LP449080-3 | Prothrombin time (PT) factor substitution 1H post incubation with 1:4 normal plasma | METHOD | 2 |
| LP449081-1 | Prothrombin time (PT) factor substitution 1H post incubation with normal plasma | METHOD | 2 |
| LP449082-9 | Prothrombin time (PT) factor substitution 2H post incubation with 1:1 normal plasma | METHOD | 2 |
| LP449083-7 | Prothrombin time (PT) factor substitution 2H post incubation with 1:4 normal plasma | METHOD | 2 |
| LP449084-5 | Prothrombin time (PT) factor substitution 2H post incubation with normal plasma | METHOD | 2 |
| LP449085-2 | Prothrombin time (PT) factor substitution 2 hours post incubation | METHOD | 1 |
| LP449086-0 | Prothrombin time (PT) factor substitution with 1:4 normal plasma 1H post incubation separate tubes | METHOD | 1 |
| LP449087-8 | Coag.tissue factor induced.factor substitution.immediately after 1:1 addition of normal plasma.control | METHOD | 1 |
| LP449088-6 | Prothrombin time (PT) factor substitution immediately after 1:4 addition of normal plasma | METHOD | 2 |
| LP449089-4 | Prothrombin time (PT) factor substitution immediately after addition of factor VIII depleted plasma | METHOD | 1 |
| LP449090-2 | Prothrombin time (PT) factor substitution immediately after addition of normal plasma | METHOD | 2 |
| LP449091-0 | Prothrombin time (PT) factor substitution | METHOD | |
| LP449092-8 | Prothrombin time (PT) factor substitution with normal plasma 1H post incubation separate tubes | METHOD | 1 |
| LP449094-4 | INR | METHOD | 5 |
| LP449095-1 | Prothrombin time (PT) | METHOD | 1 |
| LP449096-9 | Prothrombin time (PT) | METHOD | 20 |
| LP449097-7 | US.tissue factor induced | METHOD | |
| LP449098-5 | Tissue factor induced+platelet glycoprotein IIb-IIIa receptor inhibited | METHOD | |
| LP449099-3 | XXX induced | METHOD | |
| LP449100-9 | Coagulation actual/normal | COMPONENT | 18 |
| LP449101-7 | Coagulation^baseline | COMPONENT | 2 |
| LP449102-5 | Coagulation^3rd specimen | COMPONENT | 1 |
| LP449103-3 | Coagulation^4th specimen | COMPONENT | 1 |
| LP449104-1 | Coagulation normal/actual | COMPONENT | 3 |
| LP449105-8 | Coagulation^2nd specimen | COMPONENT | 1 |
| LP449106-6 | Coagulation^12H post XXX challenge | COMPONENT | 2 |
| LP449107-4 | Coagulation^18H post XXX challenge | COMPONENT | 1 |
| LP449108-2 | Coagulation^1D post XXX challenge | COMPONENT | 2 |
| LP449109-0 | Coagulation^30M post XXX challenge | COMPONENT | 2 |
| LP449110-8 | Coagulation^3H post XXX challenge | COMPONENT | 2 |
| LP449111-6 | Coagulation^4H post XXX challenge | COMPONENT | 2 |
| LP449112-4 | Coagulation^6H post XXX challenge | COMPONENT | 2 |
| LP449113-2 | Coagulation^8H post XXX challenge | COMPONENT | 2 |
| LP449119-9 | Delta Coagulation | COMPONENT | 1 |
| LP449120-7 | Coagulation^1H post XXX challenge | COMPONENT | 2 |
| LP449121-5 | Coagulation^2H post XXX challenge | COMPONENT | 2 |
| LP449122-3 | Coagulation^2H pre XXX challenge | COMPONENT | 2 |
| LP449123-1 | Coagulation^1.5H post XXX challenge | COMPONENT | 2 |
| LP449127-2 | Maximum clot strength amplitude | COMPONENT | 26 |
| LP449128-0 | Platelet-induced clot retraction | COMPONENT | 2 |
| LP449133-0 | Reduction in clot strength^30M post maximum clot amplitude | COMPONENT | 3 |
| LP449134-8 | Reduction in clot strength | COMPONENT | 1 |
| LP449137-1 | Coagulation.INR goal | COMPONENT | 1 |
| LP449173-6 | Aminoglycoside Mix (Gentamicin+Lincomycin+Neomycin+Streptomycin+Tobramycin) | COMPONENT | |
| LP449180-1 | Do you own, lease, or rent it | COMPONENT | 1 |
| LP449185-0 | Honeydew | COMPONENT | |